Fengycin
Based on 2 publication(s) in Google Scholar
Fengycin is a lipopeptide with antifungal and antitumor activities, which can be isolated and extracted from Bacillus subtilis. Fengycin primarily disrupts the target lipid bilayer through its amphipathic nature, leading to cell membrane rupture, and in tumor cells, it induces ROS production, mitochondrial damage, and calcium overload to activate caspase-3/9-mediated apoptosis, while simultaneously downregulating cyclin D1/CDK4 to cause G0/G1 phase cell cycle arrest. Fengycin can be used for research on fungal infections and various cancers.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 102577-03-7
-
Stockage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Activité biologique
Description
IC50 & Target
[1]|
Lipopeptide |
Cdk4/cyclin D1 |
Caspase-3 |
Caspase-9 |
In Vitro
Fengycin (5-800 µg/mL; 24-72 h) reduces 95D cell viability in a dose- and time-dependent manner, with IC50 values of 239.9, 177.8, and 154.9 µg/mL at 24, 48, and 72 h, respectively[2].
Fengycin (100-400 µg/mL; 12-48 h) exhibits dose- and time-dependent activity in disrupting cell membrane integrity and inducing lactate dehydrogenase (LDH) release in 95D cells, while having no effect on normal HELF cells[2].
Fengycin (200 µg/mL; 3-24 h) downregulates the mRNA expression of cyclin D1, CDK4, and Bcl-2 and upregulates the mRNA expression of Bax in 95D cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:95D, SGC-7901, A549, H460, HCT-116, MCF-7, HELF, L02 cell lines
-
Concentration:5, 25, 50, 100, 200, 400, 600, 800 µg/mL
-
Incubation Time:24 h, 48 h, 72 h
-
Result:Significantly decreased the cell survival rate of various tumor cells in a strict time- and dose-dependent manner; Fengycin did not exert significant negative effects on the viability of normal human cells such as HELF and L02.
-
Cell Line:95D cell line
-
Concentration:100, 200, 400 µg/mL
-
Incubation Time:24 h, 48 h
-
Result:Increased the percentage of cells undergoing early and late apoptosis in a time- and dose-dependent manner.
-
Cell Line:95D cell line
-
Concentration:200 µg/mL
-
Incubation Time:6 h, 12 h, 24 h
-
Result:Enhanced the activity of executioner caspase-3 and initiator caspase-9, but did not alter the activity level of caspase-8.
-
Cell Line:95D cell line
-
Concentration:100, 200, 400 µg/mL
-
Incubation Time:6 h, 12 h, 24 h
-
Result:Arrested the cell population at the G0/G1 phase in a time- and dose-dependent manner, correspondingly reducing the proportion of cells in the S and G2/M phases.
-
Cell Line:95D cell line
-
Concentration:200 µg/mL
-
Incubation Time:6 h, 12 h, 24 h
-
Result:Down-regulated the expression of cell cycle regulators cyclin D1 and CDK4, up-regulated the expression of pro-apoptotic proteins Bax and Apaf-1, down-regulated anti-apoptotic proteins Bcl-2 and PARP, promoted the release of cytochrome c into the cytoplasm, and led to the cleavage and activation of procaspase-3 and procaspase-9.
-
Cell Line:95D cell line
-
Concentration:200 µg/mL
-
Incubation Time:3, 6, 12, 24 h
-
Result:Decreased CDK4 and cyclin D1 mRNA levels in a time-dependent manner.\nBax mRNA increased over 24 h, whereas Bcl-2 mRNA decreased.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/C athymic nude ([female; 4-6 weeks old; 18-22 g])[2]
-
Dosage:40 mg/kg, 20 mg/kg, and 10 mg/kg
-
Administration:i.p.; once daily; 21 days
-
Result:Inhibited the growth of xenografted 95D tumors in a dose-dependent manner.
At 40 mg/kg, a 67% reduction in tumor weight was achieved.
Product Details
-
Structure Classification
-
Initial Source
Bacillus subtilis
Chemical Information
-
CAS No. 102577-03-7
-
Appearance Solid
-
Color White to off-white
-
SMILES
[Fengycin]
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Int J Mol Sci
Defense Responses Stimulated by Bacillus subtilis NCD-2 Through Salicylate- and Jasmonate-Dependent Signaling Pathways Protect Cotton Against Verticillium Wilt. [Abstract]2025 Mar 25;26(7):2987. PMID: 40243600 -
Sci Rep
Fengycin deficiency in Bacillus subtilis Pfen-1 increases antagonism and reveals a non-functional role against Sclerotinia sclerotiorum. [Abstract]2026 May 1;16(1):20252. PMID: 42067572
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Fengycin
- 102577-03-7
- Endogenous Metabolite
- Fungal
- Reactive Oxygen Species (ROS)
- Caspase
- Apoptosis
- CDK
- Cyclin dependent kinase
- antifungal activity
- apoptosis
- cell-cycle arrest
- ergosterol
- filamentous fungi
- lipid bilayers
- lung cancer
- membrane-perturbing lipopeptide
- mitochondrial membrane potential
- reactive oxygen species
- Inhibitor
- inhibitor
- inhibit